Neuralink Implants First Brain Chip in Human - Revolutionary Breakthrough for Paralysis and SCI/ALS Patients

Saturday - February 3 2024, 09:43 UTC - 9 months ago

In February 2024, Neuralink successfully implanted their first brain chip in a human subject, marking a major breakthrough for medical technology. The device is already detecting neuron spiking and has the potential to restore autonomy for those with paralysis or ALS. The PRIME Study is an ongoing trial to evaluate its safety and functionality, and could pave the way for safer and more effective brain-computer interfaces.

In a groundbreaking leap for medical technology, the team at Neuralink has successfully implanted their first brain chip in a human subject. The procedure, which took place in February 2024, marks a major milestone in the company's mission to create a generalized brain interface that can restore autonomy to individuals with unmet medical needs and unlock human potential.The patient who received the brain chip is currently recovering well, and the device is already detecting neuron spiking, a promising sign for the future of this technology .

This groundbreaking achievement has given new hope to those who suffer from quadriplegia caused by spinal cord injury (SCI) or amyotrophic lateral sclerosis (ALS).Neuralink's revolutionary brain chip, known as the PRIME Study (Precise Robotically Implanted Brain-Computer Interface), is an ongoing investigational medical device trial. The goal of this trial is to evaluate the safety and functionality of the company's fully-implantable, wireless brain-computer interface for individuals with SCI or ALS .

The procedure involves placing a small, cosmetically invisible implant into a part of the brain that controls movements. This implant is designed to interpret a person's neural activity, allowing them to operate a computer or smartphone simply by thinking about the movement, without the need for wires or physical movement.The PRIME Study is the first of its kind to be performed on humans, and it has the potential to significantly improve the lives of those living with paralysis or ALS .

By paving the way for safer and more effective ways to implant and use brain-computer interfaces, Neuralink's research could bring about a revolutionary change in the field of medical technology.If you have limited or no ability to use both hands due to cervical spinal cord injury or amyotrophic lateral sclerosis (ALS), you may qualify for the PRIME Study. To learn more about the study and to submit your application, please visit our website or watch our informational video .